macreexports

Indian Pharma marching towards top

2,89,998 crores is the Indian pharma business in 2019-20.

20 Percent of world’s Pharma supply from India.

World Largest producer of vaccines

100 percent growth in last 8 years

10500 manufacturing units 28 – 30% supply in USA from India ensuring the world class quality and norms.

Growth of Pharma export is 66% over last year

Key potential area and growth opportunity.

More than 70% of ksm and API is still imported, majorly from China.

15 API molecules will be out of patent in next 3 years which consist more than 100 billion dollar business globally.

Bio similars could be a alternate of patent with the help of academia.

Comments

Popular posts from this blog

m care pharma exports from india